Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HRT clinical evaluation guidance

Executive Summary

Sponsors of estrogen/progestin combination clinical trials should "identify the lowest effective dose" of estrogen and progestin to support an indication for moderate to severe vasomotor symptoms and vulvar and vaginal atrophy associated with menopause, FDA draft guidance says. The guidance, "Estrogen and Estrogen/Progestin Drug Products to Treat Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms - Recommendations for Clinical Evaluation," notes that the hormone combination may be associated with an increased risk of breast cancer and cardiovascular events. The "lowest effective dose" recommendation comes although "specific relationships between dose, exposure, and the risk of adverse events may not be known." The draft guidance would replace 1995 recommendations that FDA withdrew following publication of WHI study results (1"The Pink Sheet" July 15, 2002, p. 11)...
Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS041247

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel